2012 IW US 500 Company Profile

Johnson & Johnson JNJ NYS
Pharmaceuticals
New Brunswick, New Jersey
2012 IW US 500 Rank:
Current Rank : 19
Prior Rank : 18
Executive 1 : William C. Weldon, Chairman, Chief Executive Officer,
Executive 2 : Alex Gorsky, Chief Executive Officer, Division Officer
19 of 500
2011 Revenue (US$ Millions)$65,030
2010 Revenue (US$ Millions)$61,587
Revenue Growth (%)5.59%
Net Income (US$ Millions)$9,672
Common Shares Outstanding (Millions)2,724.36
Earnings Per Share (US$)$3.49
Earnings Per Share Growth (%)(26.99%)
Price To Earnings Ratio19.19
Total Equity (US$ Millions)$57,080
Profit Growth (%)(27.46%)
Profit Margin (%)14.87%
Return On Equity (%)17.09%
Long Term Debt (US$ Millions)$12,969
Debt To Equity Ratio (%)0.23%
Market Capitalization (US$ Millions)$178,664
Total Assets (US$ Millions)$113,644
Return on Assets (%)9.4%
Current Assets (US$ Millions)$54,316
Inventories (US$ Millions)$6,285
Current Liabilities (US$ Millions)$22,811
Cost of Goods Sold (US$ Millions)$20,360
Asset Turnover0.57
Inventory Turnover3.49

Subscribe to IW Newsletters

IW Marketplace - Buy a Link Now